Bridgefront Capital’s AtriCure ATRC Stock Holding History

Bridgefront Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,506	Closed	-$495K	–	533
2025 Q4	$495K	Buy	+12,506	New	+$458K	0.12%	274
2024 Q2	–	Sell	-8,668	Closed	-$264K	–	484
2024 Q1	$264K	Buy	+8,668	New	+$290K	0.2%	229
2023 Q2	–	Sell	-6,240	Closed	-$259K	–	450
2023 Q1	$259K	Buy	+6,240	New	+$259K	0.16%	252
2022 Q2	–	Sell	-3,577	Closed	-$235K	–	302
2022 Q1	$235K	Buy	+3,577	New	+$232K	0.29%	167

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgefront Capital's ATRC Position: Q1 2026 in Review

Bridgefront Capital sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 12,506 shares — an estimated $495K sold.

Bridgefront Capital first reported a position in ATRC in Q1 2022 and held it in 4 quarters. The position peaked at $495K in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Bridgefront Capital reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
Bridgefront Capital sold 12,506 AtriCure shares in Q1 2026, an estimated $495K.
Bridgefront Capital first reported a position in AtriCure in Q1 2022 and held it in 4 quarters.
Bridgefront Capital's AtriCure position peaked at $495K in Q4 2025.
223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.